The ramping doesn't work., page-29

First 29 Last

Share
Profile

Follow
bruham

5,529 Posts.

827

11/08/23

12:22

Post #: 69288630
Share

Originally posted by BOT: ↑

Hi rampers

I understand that you wish to pump up the stock price with lofty claims and by telling others to ignore 'downrampers'. I won't get into the legalities of this practice which ASIC has been clamping down on.

The truth is that the downrampers which you've been told to ignore are correct and would have saved you much money had you considered their views.

The attempts to pump up the stock price is having the opposite of the desired effect for the following reasons.

Firstly, rampers are just ramping to fellow retail. It's not enough money to move a $1b company up in price.

Secondly, smart money sold at the top. In fact they created the top. Retail dreamers have been buying all the way down due to them being victims of the marketing from the rampers.

When the share price falls below the buy price that these victims, aka weak hands, pray for the share price to return to the price they paid so they can exit. This created overhead pressure.

An example is right in from of you. After the banquet of bull that was served up when price jumped to 16c yesterday, now the victims that paid those prices are cutting their losses. This is why the price is at 14.5c again. This has been happening all the way down from 39c.

Until big and smart hands step in (likely on the other side of a recession), price will keep on bobbing up and being smashed down to new lows.

I've seen this on hundreds of stocks over the past 20 years. The key to making good money is being long when times are good and being out when times are bad. Makes perfect sense but so few people are able to do this as the greed emotion is too powerful.

If you're happy being poor but not alone, then carry on. But if you wan't to make money......

All IMO.
None of the above is legal advice. Just common sense.

Expand

QUOTE
"An example is right in from of you. After the banquet of bull that was served up when price jumped to 16c yesterday, now
the victims that paid those prices are cutting their losses.
This is why the price is at 14.5c again. This has been happening all the way down from 39c".

Those you are saying are cutting their losses could be long term holders taking their profits.
Which I have a mind to do, finger on the sell button.

Although, I do see you are still a holder.

SYA Price at posting: 13.5¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

IRE

Iress runs 'hot' for Wealth Within's stock tips

LU7

Strong PFS numbers solidify Lithium Universe's big plans for Québec

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Failure to report prompts ASX to impose multiple company suspensions

There are more pages in this discussion • 46 more messages in this thread...

First 29 Last

Add SYA (ASX) to my watchlist

(20min delay)
Last 3.3¢		Change -0.002(5.71%)		Mkt cap ! $339.6M

Open	High	Low	Value	Volume
3.5¢	3.6¢	3.3¢	$1.707M	49.50M

Buyers (Bids)

No.	Vol.	Price($)
41	9042151	3.3¢

Sellers (Offers)

Price($)	Vol.	No.
3.4¢	1735970	10

View Market Depth

No.	Vol.	Price($)
40	8792151	0.033
34	7855484	0.032
32	4901869	0.031
48	9497144	0.030
35	7996987	0.029

Price($)	Vol.	No.
0.034	1702670	9
0.035	3534854	11
0.036	4841883	17
0.037	5754895	18
0.038	6174516	16

Last trade - 16.10pm 01/10/2024 (20 minute delay)

SYA (ASX) Chart

The ramping doesn't work., page-29

Iress runs 'hot' for Wealth Within's stock tips

Strong PFS numbers solidify Lithium Universe's big plans for Québec

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Failure to report prompts ASX to impose multiple company suspensions

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

The ramping doesn't work., page-29

Top Stories

Iress runs 'hot' for Wealth Within's stock tips

Strong PFS numbers solidify Lithium Universe's big plans for Québec

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Failure to report prompts ASX to impose multiple company suspensions

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News